Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:01 pm Sale |
2024-12-31 | 13G | Pyxis Oncology, Inc. PYXS |
Ridgeback Capital Investments L.P. | 359,231 0.600% |
-3,985,997 (-91.73%) |
Filing History |
| 2024-07-29 4:12 pm Purchase |
2024-07-17 | 13G | LENZ Therapeutics, Inc. LENZ |
Ridgeback Capital Investments L.P. | 1,951,875 7.200% |
1,951,875 (New Position) |
Filing History |
| 2024-02-14 4:08 pm Sale |
2023-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Ridgeback Capital Investments L.P. | 844,235 2.200% |
-1,420,566 (-62.72%) |
Filing History |
| 2024-02-14 4:07 pm Purchase |
2023-12-31 | 13G | Affimed N.V. AFMD |
Ridgeback Capital Investments L.P. | 1,485,898 9.900% |
197,637 (+15.34%) |
Filing History |
| 2024-01-26 4:36 pm Purchase |
2024-01-26 | 13G | Pyxis Oncology, Inc. PYXS |
Ridgeback Capital Investments L.P. | 4,345,228 9.800% |
4,345,228 (New Position) |
Filing History |
| 2023-02-14 4:06 pm Unchanged |
2022-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Ridgeback Capital Investments L.P. | 2,264,801 7.600% |
0 (Unchanged) |
Filing History |
| 2023-02-14 4:06 pm Unchanged |
2022-12-31 | 13G | Affimed N.V. AFMD |
Ridgeback Capital Investments L.P. | 1,288,261 8.800% |
0 (Unchanged) |
Filing History |
| 2023-02-14 4:06 pm Unchanged |
2022-12-31 | 13G | F-star Therapeutics, Inc. FSTX |
Ridgeback Capital Investments L.P. | 52,509 0.200% |
0 (Unchanged) |
Filing History |
| 2023-02-14 4:02 pm Sale |
2022-12-31 | 13G | F-star Therapeutics, Inc. FSTX |
Ridgeback Capital Investments L.P. | 52,509 0.200% |
-1,781,851 (-97.14%) |
Filing History |
| 2023-02-14 4:02 pm Purchase |
2022-12-31 | 13G | Affimed N.V. AFMD |
Ridgeback Capital Investments L.P. | 1,288,261 8.800% |
516,050 (+66.83%) |
Filing History |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Ridgeback Capital Investments L.P. | 2,264,801 7.600% |
100,000 (+4.62%) |
Filing History |
| 2022-02-14 4:15 pm Purchase |
2021-12-31 | 13G | F-star Therapeutics, Inc. FSTX |
Ridgeback Capital Investments L.P. | 1,834,360 8.900% |
1,340,000 (+271.06%) |
Filing History |
| 2022-02-14 4:14 pm Sale |
2021-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Ridgeback Capital Investments L.P. | 0 0.000% |
-1,252,250 (Position Closed) |
Filing History |
| 2022-02-14 4:13 pm Purchase |
2021-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Ridgeback Capital Investments L.P. | 2,164,801 7.400% |
302,968 (+16.27%) |
Filing History |
| 2022-02-14 4:12 pm Purchase |
2021-12-31 | 13G | Affimed N.V. AFMD |
Ridgeback Capital Investments L.P. | 772,211 6.500% |
127,211 (+19.72%) |
Filing History |
| 2021-04-14 11:25 am Purchase |
2021-04-09 | 13G | Affimed N.V. AFMD |
Ridgeback Capital Investments L.P. | 645,000 5.500% |
645,000 (New Position) |
Filing History |
| 2021-04-09 4:54 pm Purchase |
2021-03-30 | 13G | F-star Therapeutics, Inc. FSTX |
Ridgeback Capital Investments L.P. | 494,360 5.400% |
86,793 (+21.30%) |
Filing History |
| 2021-02-16 4:23 pm Sale |
2020-12-31 | 13G | Verastem, Inc. VSTM |
Ridgeback Capital Investments L.P. | 0 0.000% |
-839,020 (Position Closed) |
Filing History |
| 2021-02-16 4:22 pm Sale |
2020-12-31 | 13G | Sutro Biopharma, Inc. STRO |
Ridgeback Capital Investments L.P. | 1,144,979 2.500% |
-869,708 (-43.17%) |
Filing History |
| 2021-02-16 4:21 pm Sale |
2020-12-31 | 13G | Myomo, Inc. MYO |
Ridgeback Capital Investments L.P. | 104,755 2.300% |
-35,245 (-25.18%) |
Filing History |